| Financial Year |
March 31 2023 |
| Monetary Funds |
558,659,473.23 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
4,051,270.00 |
| Accounts Receivable |
507,235,478.87 |
| Advances to Suppliers |
60,505,153.65 |
| Other Receivables |
54,126,277.62 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
10,872,240.00 |
| Inventories |
1,111,933,699.45 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
20,539,625.06 |
| Other Current Assets |
134,594,893.81 |
| Total Current Assets |
2,476,997,514.10 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
20,624,888.58 |
| Long-term Equity Investment |
35,013,595.57 |
| Investment Properties |
612,400,300.00 |
| Fixed Assetes |
8,395,512,411.41 |
| Under-construction Projects |
1,240,672,223.74 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
252,185,517.09 |
| R&D expenses |
15,028,778.37 |
| Goodwill |
116,993,051.00 |
| Long-Term Deferred and Prepaid Expenses |
789,618,489.40 |
| Deferred Income Tax Assets |
3,077,232.29 |
| Other Non-Current Assets |
6,257,346.56 |
| Sub-Total of Non-Current Assets |
12,520,156,266.59 |
| Total Assets |
14,997,153,780.69 |
| Short-Term Loans |
850,000,000.00 |
| Trading Financial liabilities |
-- |
| Notes Payable |
53,927,954.16 |
| Accounts Payable |
1,303,875,527.34 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
40,208,855.64 |
| Taxes Payable |
3,912,916.90 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
136,552,598.63 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
1,113,470,549.73 |
| Other Current Liabilities |
-- |
| Sub-Total of Current Liabilities |
4,345,988,284.06 |
| Long-term Loans |
3,004,500,000.01 |
| Bonds Payable |
288,107,556.02 |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
355,983.45 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
3,633,150,749.22 |
| Total Liabilities |
7,979,139,033.28 |
| Paid-In Capital(Or Share Stock) |
3,301,295,328.00 |
| Capital Surplus |
1,194,838,367.74 |
| Surplus Reserve |
1,472,741,092.15 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
949,129,611.67 |
| Minority Stockholder's Interest |
56,362,283.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
6,961,652,464.32 |
| Owner's Equity（Stockholder's Equity） |
7,018,014,747.41 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
14,997,153,780.69 |
